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Abstract: The Pharmacy Education in Europe (PHARMINE) project studies pharmacy practice and
education in the European Union (EU) member states. The work was carried out using an electronic
survey sent to chosen pharmacy representatives. The surveys of the individual member states are now
being published as reference documents for students and staff interested in research on pharmacy
education in the EU, and in mobility. This paper presents the results of the PHARMINE survey
on pharmacy practice and education in Finland. Pharmacies have a monopoly on the dispensation
of medicines. They can also provide diagnostic services. Proviisori act as pharmacy owners and
managers. They follow a five-year (M.Sc. Pharm.) degree course with a six-month traineeship.
Farmaseutti, who follow a three-year (B.Sc. Pharm.) degree course (also with a six-month traineeship),
can dispense medicines and counsel patients in Finland. The B.Sc. and the first three years of the
M.Sc. involve the same course. The current pharmacy curriculum (revised in 2014) is based on five
strands: (1) pharmacy as a multidisciplinary science with numerous opportunities in the working life,
(2) basics of pharmaceutical sciences, (3) patient and medication, (4) optional studies and selected
study paths, and (5) drug development and use. The learning outcomes of the pharmacy graduates
include (1) basics of natural sciences: chemistry, physics, technology, biosciences required for all
the students (B.Sc. and M.Sc.), (2) medicine and medication: compounding of medicines, holism of
medication, pharmacology and biopharmaceutics (side-effects and interactions), patient counseling,
efficacy and safety of medicines and medication, (3) comprehensive and supportive interactions of
the various disciplines of pharmacy education and research: the role and significance of pharmacy as
a discipline in society, the necessary skills and knowledge in scientific thinking and pharmaceutical
research, and (4) basics of economics and management, multidisciplinarity, hospital pharmacy,
scientific writing skills, management skills. In addition, teaching and learning of “general skills”,
such as the pharmacist’s professional identity and the role in society as a part of the healthcare system,
critical and creative thinking, problem-solving skills, personal learning skills and life-long learning,
attitude and sense of responsibility, and communication skills are developed in direct association with
subject-specific courses. Professional specialization studies in industrial pharmacy, and community
and hospital pharmacy are given at the post-graduate level at the University of Helsinki.
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1. Introduction
The Pharmacy Education in Europe (PHARMINE) consortium surveyed pharmacy practice and
education in the member states of the European Union (EU), including Finland, between 2008 and
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2011, with an update in November 2018. The methodology used in the PHARMINE study and the
main results obtained were already published [1]. In the first part of the study, PHARMINE gathered
information on community practice, and on specialized hospital and industrial practice, as well as the
necessary education and training. PHARMINE also dealt with other personnel working in pharmacies
such as pharmacists’ assistants: their education, training, and responsibilities.
PHARMINE went on to study the legal and administrative context of pharmacy practice and
education. In the EU, pharmacy practice and education fall under two jurisdictions: European and
national. EU legislation is confederal in structure. Freedom of movement and of exercise of profession is
the cornerstone. To ensure this, there is a system of automatic recognition of professional qualifications
for sectoral professions such as not only pharmacists, but also nurses, midwives, doctors, dentists,
architects, and veterinary surgeons. To work in another EU member state, such professionals apply
to the relevant authority of that country, providing proof of the qualifications obtained in their home
state. Such procedures are regulated by directives issued by the European Commission of the EU.
The latter are ordinances laying down the broad imperatives on the practice and education of the given
profession [2]. An EU directive requires member states to achieve a particular result—in this case,
harmonization of practice and education—without dictating the means of achieving that result. Thus,
directives leave the different member states with leeway as to the exact rules to be adopted. The result
of this is that member states have systems that are more or less harmonized with the EU paradigm.
In parallel to the above pan-national system, member states may introduce national legislation
relating for example to specialized practice, and to ownership and management of pharmacies.
Pharmacy education and training in Europe is also influenced by the Bologna agreement on the
harmonization of European degree courses, and student and staff exchange [3]. The Bologna agreement
was signed by the education ministers of the governments of the European Higher Education Area
(48 members including the 28 EU member states). It proposes recommendations that are not legally
binding. The first of these is a harmonized structure for all university degrees (including pharmacy)
with a bachelor (three years) followed by a master (two years) degree. In this aspect, the Bologna
agreement is in opposition to the EU directive. The latter requires a five-year, “tunnel” degree
structure for pharmacy, i.e., a degree course that offers no possibility for intermediate entry or exit
after accomplishment of a three-year bachelor period.
The idea behind the Bologna recommendations is to improve student mobility, with the
development of tools to promote student exchange programs like the European Credit Transfer
and Accumulation System (ECTS). This provides credits to students for defined learning outcomes.
ECTS are coupled to a Diploma Supplement that describes the nature, level, context, content, and
status of the studies that were successfully completed by a student. This system allows students to
validate studies carried out at their host university by their home university.
This paper looks at how the EU directive and the Bologna recommendations apply to Finland, a
country that has been a member of the EU for quite some time (membership 1995).
In order to place practice within the general health situation in Finland compared to Europe, it can
be noted that Finland has a compulsory, tax-based healthcare system, which provides comprehensive
coverage for the entire resident population. The central government and municipalities are the main
players in the organization of healthcare. At the national level, the Ministry of Social Affairs and
Health issues framework legislation on health and social care policy and monitors implementation.
At the local level, the municipal health committee, council, and executive board make decisions on
the planning and organization of care. Municipalities (317 in 2016) are also responsible for health
promotion and disease prevention, primary medical care, medical rehabilitation, and dental care.
The country is divided into 20 hospital districts, each of which is a federation of municipalities
responsible for arranging and coordinating specialized care within their area. There is an ongoing
major reform in health and social care in Finland currently, which will probably cause numerous
changes in arrangements and responsibilities in the area [4].
Pharmacy 2019, 7, 21 3 of 15
In 2015, the total healthcare expenditure in Finland was €19.8 billion, with an annual growth of
1.2%. This means 9.4% of gross domestic product. Specialized medical care costs were €6.9 billion
and basic medical care costs were €3.7 billion. Drug costs and medical supplies were €2.5 billion
(+4.0% compared to 2014). Public funding covered 74.6% (−1% compared to 2014) and private funding
covered 25.4% of healthcare costs in Finland in 2016 [5]. Pharmaceutical care is an integral part of
social and healthcare. The Ministry of Social Affairs and Health is responsible for the development
of pharmaceutical care and preparing legislation concerning pharmaceuticals. The aim is to have an
efficient, safe, appropriate, and cost-effective system of medical treatment available to all who need it.
The proper availability and professionally competent distribution of pharmaceuticals is safeguarded at
all times.
2. Design
Information was obtained from academics and practicising pharmcists (the authors) and from
internet sources (university websites) on the following:
• pharmacy:
# practice (community, hospital, and industrial);
# legislation;
# education and training;
• harmonization with the EU sectoral directive on pharmacy [2] and with the Bologna
recommendations [6].
Electronic survey methodology was used; data were collected in 2010 and revised in 2017–2018.
Sampling was performed by sending the survey to all pharmacy departments, pharmacy orders and
chambers, associations of industrial, hospital, and other specialization pharmacists, and associations of
pharmacy students. Collection of data in any specific country took between six and 12 months. Data
collection was performed electronically using standard survey platforms. We attempted at all times to
collect objective, if possible, numerical data.
The information is presented in the form of tables in order to facilitate legibility. This presentation
was developed in association with the Pharmacy journal editorial board; it is based on the organization
of the PHARMINE survey [1], and was described in detail in a previous publication [7]. This format
will ease the comparison of different EU countries by students and staff envisaging exchange programs,
and by researchers in pharmacy education and practice.
3. Evaluation and Assessment
In order to follow the terminology of Finnish pharmacy degrees, three major personnel categories
can be separated from each other as follows:
Pharmacy personnel in Finland
M.Sc. Pharm. (Proviisori) = Pharmacists who dispense medicine and counsel patients; the degree
is a requirement for pharmacy owners and managers—a five-year university education.
B.Sc. Pharm. (Farmaseutti) = Pharmacists who dispense medicine and counsel patients in
pharmacies but cannot own a pharmacy or be a head manager in a pharmacy—a three-year university
education.
Pharmacy technician (Lääketeknikko) = Supporting personnel in pharmacies taking care of medicine
storage, logistics, invoicing, and cash services—a 2–3-year upper secondary vocational education.
3.1. Organization of the Activities of Pharmacists, Professional Bodies
Table 1 provides details of the numbers and activities of community pharmacists and pharmacies
in Finland. Items are expounded in the “comments” column.
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Table 1. Numbers and activities of Finnish community pharmacists and pharmacies.
Item Number Comments.
Community
pharmacists
772 M.Sc.
pharmacists + 594
pharmacy
owners = 1366
There are additionally 3724 bachelor-level pharmacists working
in community pharmacies. The total number of employees in
community pharmacies is circa 8500.
Community
pharmacies 610 + 200 = 810
610 pharmacies and 200 subsidiary or branch pharmacies—the
same medicines and services are available from both types of
pharmacies. There are approximately 1 pharmacist (M.Sc.) and
4.5 bachelor pharmacists per pharmacy, and 6600 inhabitants
per pharmacy.
Competences and
roles of community
pharmacists
Pharmacists work as the following:
• dispensing staff members
• pharmacy owners, managers,
• specialist pharmacists (after professional post-gradute
studies).
Competences include administrative issues, customer service,
medication review, marketing, education of pharmacy staff, and
multidisciplinary co-operation with other healthcare
professionals.
Pharmacists provide services to help patients monitor the
therapeutic control of blood sugar or blood pressure.
Ownership limited to
pharmacists? Yes
A license to own a pharmacy is granted to a person having a
5-year degree in pharmacy with a 6-month traineeship (M.Sc.
Pharm.).
Are there rules
governing the
geographical
distribution of
community
pharmacies? [8]
Yes
The location of community pharmacies is based on the decision
made by the Finnish Medicine’s Agency (FIMEA)
(https://www.fimea.fi/web/en). FIMEA evaluates if there is a
need for one (or multiple) community pharmacies in some
particular area and specifies also the area where the pharmacy
or pharmacies should be located. Within that specific area,
pharmacies are free to choose their exact location.
This system assures equal accessibility to medicines and
pharmacy services for the whole population.
Are drugs and
healthcare products
available to the
general public by
other channels?
No
In Finland, medicines are sold to the public only from
pharmacies, with the exception that nicotine replacement
therapy (NRT) products may also be available in grocery shops.
However, many pharmacies offer internet shop alternatives for
healthcare products and over-the-counter drugs.
Veterinary drugs are also available from veterinarians.
Using the data in Reference [1] and Table 2, it can be calculated that, compared to the EU linear
regression estimation (for definition and calculation, see Reference [1]), the ratio of the number of
community pharmacists in Finland to the population compared to the linear regression estimation
= 0.40. Thus, the number of pharmacists per population is lower than the EU norm. The same
comparison for community pharmacies produces a ratio of 0.5, lower than the EU norm. This may
reflect the separate activities of pharmacists compared to other healthcare professionals.
The activities and occupations of pharmacists in Finland are similar to those of community
pharmacists in other EU member states [1].
Table 2 provides details of the numbers and activities of persons other than pharmacists working
in pharmacies in Finland.
Finland is one of the rare if not the only country in the EU which follows the Bologna principles
to the letter. Thus, there are separate three- (B.Sc. Pharm.) and five-year (M.Sc. Pharm.) degrees each
with a job profile following graduation. This topic is discussed in detail later.
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Table 2. Numbers and activities of other personnel working in pharmacies in Finland.
Item Number Comments
Are persons other than
pharmacists involved in
community practice?
Yes These are pharmacy technicians.
Only persons with either a B.Sc.Pharm. or a M.Sc.Pharm.
degree are allowed to dispense and counsel patients on
medicines.
A pharmacist (M.Sc.degree) is responsible for the operation of
the pharmacy.
Their titles and number(s) 3486 Pharmacy technicians with upper secondary vocational
education (corresponds to “pharmacy assistants”)
Their qualifications
Organization providing and
validating the education and
training.
Upper secondary vocational education
Duration of studies 2–3 years
Subject areas Pharmacy technicians study logistics, accounting, and
information technology (IT) skills. Education consists of
theoretical studies and a larger part of in-house training.
Competences and roles Pharmacy technicians:
Their main task is to take care of medicine storage and
logistics in the community pharmacy. They also take care, for
example, of invoicing and operating of pharmacy IT systems.
Table 3 provides the numbers and activities of hospital pharmacists in Finland.
Table 3. Numbers and activities of hospital pharmacies and pharmacists in Finland.
Item Number Comment
Number of hospital
pharmacists
696 605 (B.Sc.) + 91 (M.Sc.)
Number of hospital
pharmacies
154 There are 24 hospital pharmacies that are in central hospitals and 81
medicine centers which are in other hospitals or healthcare centers.
University hospitals are the largest hospitals in Finland. There are
five university hospitals that are located in the bigger cities
(Helsinki, Tampere, Turku, Oulu, and Kuopio: in cities where there
is a university with a medical faculty).
Central hospitals are the most central and larger hospitals in some
other particular hospital districts. Each central hospital is under the
supervision of a given university hospital.
Competences and roles
of hospital pharmacists
In most hospitals, the hospital pharmacy or the medicine center is
one of the medical service departments. The manager of a hospital
pharmacy is required to have an M.Sc. in pharmacy, while the
manager of a medicine centre is required to have an M.Sc. or B.Sc.
in pharmacy. A manager of a hospital pharmacy or a dispensary is
usually authorized by the medical director of the hospital.
B.Sc. and M.Sc. hospital pharmacists used to have a logistic role in
hospitals and healthcare centers. The role is now starting to change,
and some pharmacists are working in the wards. A professional
post-graduate specialization program for hospital pharmacists
started in 2010 to ensure stronger competencies for the hospital
pharmacists to work as clinical specialists (see more details of the
specialized education in Table 7).
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The number of pharmacists working in hospitals is lower than the EU average. The ratio of the
actual number compared to the linear regression estimation is 1.94, (for definition and calculation, see
Reference [1]). The duties of hospital pharmacists are similar to those elsewhere in the EU [1].
Turning to pharmacists in industry and in other sectors, Table 4 provides such information on
these sectors in Finland.
Table 4. Pharmaceutical industry, and numbers and activities of pharmacists in industry and in other
sectors in Finland.
Pharmaceutical and Related Industries
Item Number Comment
Number of companies
with production, research and
development (R&D) and
distribution
4 Pharmaceutical production: 1598 million € (m€)
Pharmaceutical exports: 852 m€; imports: 2010 m€
(balance −1158 m€)
Research and development: 172 m€
Employment in the pharmaceutical industry: 5233
Pharmaceutical market value: 2246 m€
Share of generics in market sales: 25%
The above figures are from The Pharmaceutical Industry in
Figures, European Federation of Pharmaceutical
Industries and Associations, EFPIA, Key figures 2017 [9].
Companies with production only 3
Companies with distribution only 2
Number of pharmacists working
in industry
400 M.Sc. and
400 B.Sc.
Other sectors
Number of pharmacists working
in other sectors
320 This information is based on the report by
Akava—Confederation of Unions for Professional and
Managerial Staff in Finland in 2008 [10].
Sectors in which pharmacists
are employed
Academic sector, e.g., pharmacists working in
universities and research organizations (160)
Administration, e.g., pharmacists working in Finnish
national authorities (Finnish Medicines Agency, Ministry
of Social Affairs and Health, National Insurance
Institution) (60)
Other: unspecified (100)
Competences and roles of
pharmacists employed in
other sectors
Teaching, research, administration, management,
and leadership
Varying roles and competencies: specialist pharmacists
(pharmacists specialized in some specific issues, for
example, marketing authorizations, pricing and
re-imbursement of medical products, IT-issues such as
e-prescriptions and databases, medicine information),
researchers, managers
Table 5 provides information on professional associations for pharmacists in terms of number,
territorial distribution, and ethical and professional attributes in Finland.
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Table 5. Professional associations for pharmacists in Finland.
Item Reply Comments
Registration of
pharmacists
Yes.
There are circa
2000 registered
pharmacists in
Finland.
Issued by Valvira (National supervisory authority for Welfare
and Health) [11].
Creation of community
pharmacies and control
of territorial distribution
Yes Issued by Finnish Medicines Agency (FIMEA) [8]. From the
FIMEA website:
Under Section 40 of the Medicines Act, the operation of a
pharmacy business requires a licence (pharmacy licence)
issued by FIMEA.
The conditions under which a pharmacy licence may be
granted according to the Section 43 of the Medicines Act are
as follows:
“A pharmacy licence may be granted to citizen of a European
Economic Area state who is a certified Master of Pharmacy
and who has not been declared bankrupt or legally
incompetent or who has not been assigned a person to
supervise his or her interests. If there is more than one
applicant, a pharmacy licence is granted to the applicant who
can be considered to have the overall best potential for
operating a pharmacy business. In assessing the potential, the
applicant’s work in pharmacies and other pharmaceutical
services and studies, managerial skills, and other activities
pertinent to operating a pharmacy business must be taken
into account.”
Ethical considerations
and role of pharmacists
in healthcare
Yes There is an advisory board on ethical issues in pharmacies
based on the co-operation between Pharmacy Owners’
Association (AFP [12]) and Finnish Pharmacists’ Association
(SFL [13]). Additionally, there exists a national ethical code of
conduct produced by abovementioned organizations.
In order to strengthen the role of community pharmacies in
healthcare and to support the professional development, the
Association of Finnish Pharmacists established a national
strategy in 1997 that concerned pharmacy services and
pharmacy role in healthcare. This strategy highlighted the
importance of medication counseling in community
pharmacies: whenever medicines are dispensed, information
should also be provided. National long-term programs
focusing on chronic diseases (asthma, diabetes, and heart
diseases) were organized to encourage local co-operation
between pharmacies and other healthcare professionals and to
develop the competency and counseling skills of
pharmacy staff.
Quality assurance and
validation of
higher-education
institution (HEI) courses
for pharmacists
No The universities providing pharmacy education have their
own quality handbooks and quality assurance procedures.
In the University of Helsinki, for example, feedback is
collected from students and internal and
external/international audits are made regularly.
3.2. Pharmacy Faculties, Students, and Courses
Table 6 provides detailed numbers and activities of pharmacy higher-education institutions (HEIs),
staff, and students in Finland.
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Table 6. Pharmacy higher-education institutions (HEIs), staff, and students in Finland.
Item Reply and/or Number Comments
Total number of HEIs for
pharmacy
3 Helsinki, Kuopio, Turku.
In total, there are 14 universities and 23
universities of applied sciences in Finland.
Public HEIs 3
Organization of HEIs
Independent faculty Yes University of Helsinki, Faculty of Pharmacy
Attached to a medical faculty Yes University of Eastern Finland, Faculty of
Health Sciences, in Kuopio
Attached to a science faculty Yes Åbo Akademi University, Faculty of
Mathematics and Natural Sciences, in Turku
Do HEIs offer B.Sc. and M.Sc.
degrees?
Yes Universities of Helsinki and Eastern Finland
Do HEIs offer a M.Sc. Pharm.
after a B.Sc. degree in another
discipline?
Yes
Finland
Teaching staff
Number of teaching staff (from Finland) circa 260
Number of international teaching staff
(from European Union (EU) MSs)
circa 30
Number of international teaching staff (non-EU) circa 20
Number professionals (pharmacists and others) from
outside the HEI, involved in education and training.
circa 50
Students
Places on entry after secondary
school
350 + 110 The numbers are rounded. All students follow
the same course for the first 3 years with 350
having the right to study only B.Sc. Pharm.
(and taking up employment after graduating),
and 110 going on for two further years to a
M.Sc. Pharm.
Number of applicants for entry 3000 Approximately 6 applicants for 1 place.
Number that become
professional pharmacists.
350 B.Sc. + 110 M.Sc. Around 350 take up employment after
graduating B.Sc. and do not have the right to
continue with the M.Sc. course. Around 110
continue with the M.Sc. course.
Number of international
students (from EU member
states (MS))
circa 75 Exchange students, mostly M.Sc. students
Number of international
students (non-EU)
circa 20 Exchange students, mostly M.Sc. students
Entry requirements following secondary school (national)
Specific pharmacy-related,
national entrance examination
Yes The same national entrance examination in
pharmacy is used in all HEIs.
Is there a national numerus
clausus?
No Each institution sets its individual numerus
clausus.
Advanced entry
At which level? Some of the students have the right to pursue
both B.Sc. and M.Sc. (Pharm.) degrees. Persons
taken the B.Sc. (Pharm.) degree can apply to
the Master’s level also later.
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Table 6. Cont.
Item Reply and/or Number Comments
Specific requirements for
international students (EU or
non-EU).
Language requirements in Finnish or Swedish
for B.Sc. and M.Sc.
Fees per year
For home students 0 There are no tuition fees for national or
international B.Sc. and M.Sc. (Pharm.) degree
students.
For EU MS students 0
For non-EU students 0
Helsinki
Teaching staff
Number of teaching staff (from Finland) circa 120
Number of international teaching staff (from EU MSs) circa 20
Number of international teaching staff (non-EU) circa 20
Number professionals (pharmacists and others) from
outside the HEIs, involved in education and training.
circa 25
Students
Places on entry after secondary
school
143 + 60 All students follow the same course for the first
3 years with 143 having the right to study only
B.Sc. Pharm. (and taking up employment after
graduating), and 60 going on for two further
years to a M.Sc. Pharm.
Number of applicants for entry 1500 Approximately 7 candidates per place.
Number becoming
professional pharmacists.
150 + 50
Number of international
students (EU)
50 Exchange students, mostly M.Sc. students
Number of international
students (non-EU)
10 Exchange students, mostly M.Sc. students
Entry requirements following secondary school
HEI has a specific
pharmacy-related entrance
examination
Yes The same national entrance examination in
pharmacy is used in all HEIs.
Advanced entry
At which level? Some of the students have the right to pursue
both B.Sc. and M.Sc. (Pharm.) degrees. Persons
taken the B.Sc. (Pharm.) degree can apply to
the Master’s level also later.
Specific requirements for
international students
(EU/non-EU).
Language requirements in Finnish or Swedish
for B.Sc. and M.Sc. degrees [14].
For exchange students no specific language
requirements. The courses taught in English in
Helsinki are listed in Reference [15].
Fees per year Free for all B.Sc. and M.Sc. (Pharm.) degree
students.
Pharmacy 2019, 7, 21 10 of 15
A comparison to the EU average for staff shows that Finland has a high ratio 2.1 [1], and the
number of pharmacy HEIs is also high compared to the EU norm at 1.5. Concerning teaching,
it is interesting to note that Finnish pharmacy HEIs offer an implemented Bologna style B.Sc.
Pharm. degree.
Table 7 below contains details of specialization electives.
Table 7. Specialization electives in pharmacy HEIs.
Item Reply and/or
Number
Comment
Does your HEI provide
specialized courses?
Yes
In which years? Both after completing the B.Sc. and the M.Sc. degree
In which specialization
(industry, hospital . . . )?
1. Industrial pharmacy
2. Community and hospital pharmacy
Specialization studies are post-graduate programs for
pharmacists (both M.Sc. and B.Sc. Pharm.) working in these
specialization areas. Studying takes place alongside work
and study plan is tailored individually to support the
student’s own development needs. The extent of studies is
60 European Credit Transfer and Accumulation System
(ECTS) for M.Sc. (Pharm.) and 40 ECTS for B.Sc. (Pharm.).
Normative duration of studies is 3–4 years. The student fee
is 6000 € for the M.Sc. graduates in Pharm. and 4000 € for
the B.Sc. graduates in Pharm. (ca. 1500 €/year).
What are the student
numbers in each
specialization?
20 In both specialization programs, the yearly intake of
Bachelors and Masters is altogether 20.
Post-graduate specialized education is offered in industrial pharmacy and in community and
hospital pharmacy.
Table 8 provides details of past and present changes in pharmacy education and training
in Finland.
Table 8. Past and present changes in education and training in Finnish pharmacy HEIs.
Item Reply Comment
Major changes before 2019
in Helsinki/Finland?
Yes Four new positions for tenure track professors were appointed to the
Faculty of Pharmacy.
The professional specialization education programs were reformed 2016.
The curricula for Bachelor’s and Master’s levels were reformed
2014–2017.
A new organization was introduced in the university for degree study
programs. The leaders and steering groups for the Bachelor and Master
study programs took action in 2016.
Major changes envisaged
in Helsinki/Finland?
Yes The implementation of the new curriculum as a whole in the degree
programs.
3.3. Teaching and Learning Methods—Student Hours
Table 9 represents teaching and learning methods in student hours.
The first year is devoted mainly to lectures and the second and third years are devoted
to traineeship.
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Table 9. Teaching and learning methods in student hours.
Method Year 1 % Year 2 % Year 3 % Year 4 * Year 5 **
Lecture 427 72 223 22 98 12 160
Practicals 36 6 189 19 46 6 0
Project work 70 12 41 4 120 14 95
Subtotal 533 453 264 255
Traineeship
Community
0 0 520
(= 13 weeks)
52 520
(= 13 weeks)
62 0
Subtotal 533 973 784 255
Electives: choice 61 28 49
Total 594 1001 833
* This represents only part of the M.Sc. course of the fourth and fifth years (see Section 4). ** The curriculum for year
5 varies student-specifically, so numbers of hours are not available. Note: “Practical” includes laboratory work and
patient counseling practice. Project work includes all group work and excercises together with writing the thesis of
B.Sc. (pharmacy) in the third year.
3.4. Subject Areas
Table 10 provides details of subject area (for definitions of the subject areas, see Reference [1]).
Table 10. Subject areas (ECTS).
Subject Area Year 1 % Year 2 % Year 3 % Year 4 § Total #
Chemical
sciences
10 ECTS
112 h
21 15 ECTS
108 h
11 220 h
Physical and
mathematical sciences
3 ECTS
28 h
5 2 ECTS
28 h
3 56 h
Biological sciences 10 ECTS
68 h
13 12 ECTS
135 h
14 203 h
Pharmaceutical
technology
5 ECTS
28 h
5 5 ECTS
84 h
8 112 h
Medical sciences 23 ECTS
166 h
32 11 ECTS
64 h
6 4 ECTS
46 h
7 276 h
Law, ethics and
societal sciences
7 ECTS
99 h
19 5 ECTS
36 h
5 135 h
Generic subjects 5 ECTS
24 h
5 3 ECTS
56 h
6 10 ECTS
68 h
10 148 h
Subtotal 525 h 475 h 150 h 255 h 1150 h
Generic subjects +
traineeship
5 ECTS
24 h
5 18 ECTS
576 h
58 25 ECTS
588 h
88 1188 h
Total 525 h 995 h 670 h 255 h 2445 h
§ Notes for the 4th year studies: in the M.Sc. degree (120 ECTS), the students take 50 ECTS general studies (of which
20 ECTS are elective) and 70 ECTS major studies. The number of hours spent in every subject area in major studies
varies from student to student. Due to this, it is difficult to give an average number of hours. The 30 ECTS of
general, compulsory studies for every M.Sc. degree student include highly integrated studies in chemical, biological,
medical, and societal sciences, together with pharmaceutical technology, pharmacoeconomics, and statistics. Due to
the integrated nature of the studies, detailed information about the hours is not available. Therefore, only a sum of
the hours of lectures, assignments, and group works is reported here. # Total hours by subject area are calculated for
the years 1–3, the total hours include also the general, compulsory studies (30 ECTS) of fourth year. The percentage
values are not informative and, therefore, are not reported here. The studies cover chemical, biological, and medical
sciences, together with pharmaceutical technology, quite evenly throughout the first two years, with the emphasis
on medical sciences in the first year. The third year is devoted mainly to generic substances together with traineeship.
All the subject areas are covered in the studies of the fourth year in a highly integrated manner.
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The hours calculated in every column represent the time scheduled for lectures, assignments, and
group works. The time a student takes for individual work is not calculated here. Students also have
to take 20 ETCS of elective studies for B.Sc. These hours were not calculated here, as the hours spent
vary for each student and may even be on non-pharmaceutical subjects.
Figure 1 shows a graphical representation of the above.
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Figure 1. A graphical representation of total hours over the studies of the first three years (B.Sc.) for
the various subject areas.
Year 1 is devoted mainly to chemical and medical sciences, year 2 is devoted to generic subjects
and pharmaceutical technology, year 3 is devoted to generic subjects and medical sciences, and
year 4 is devoted to chemical sciences and pharmaceutical technology. It can be seen that the
MEDISCI/CHEMSCI ratio in the master program (year 4 and 5) is 2.83, thus reflecting the importance
of medicinal science subjects. The overall ratio of MEDISCI/CHEMSCI (years 1–5) is 0.73. In the EU,
some HEIs such as Spain have a “balanced” course with a medicinal sciences/chemical sciences index
of 1.2. Others have more “medical” courses, such as Ireland and the Netherlands, with indices of 2.6
and 1.6, respectively [1].
3.5. Impact of the Bologna Principles [3]
Table 11 provides details the various ways in which the Bologna declaration impacts on the
pharmacy HEIs of Finland.
Pharmacy 2019, 7, 21 13 of 15
Table 11. Ways in which the Bologna declaration impacts on Finnish pharmacy HEIs.
Bologna Principle Is the Principle
Applied?
Comments
1. Comparable degrees/
diploma supplement
Yes Each graduating student receives a diploma supplement in
English
2. Two main cycles (B and M)
with entry and exit at B level
Yes We have a 3-year Bachelor and a 2-year Master program
according to the Bologna Agreement.
In the University of Helsinki, entrance is permitted each year
for 150 students (B.Sc.) and 55 students (M.Sc.). Bachelors
graduate after 3 years, and Masters graduate after 5 years.
It is possible for a person with a B.Sc. (Pharm.) to gain
entrance in the M.Sc. (Pharm.) program if passing an entrance
exam or on the grounds of good grades in the Bachelor level
studies.
Bachelors in Pharmacy are employed in Finland and Sweden
in community pharmacies, hospital pharmacies, industry, etc.
They constitute the main work force in Finnish community
pharmacies. In other parts of Europe, the degree is not
recognized.
3. ECTS system of
credits/links to LLL
(life-long learning)
Yes All our courses are built according to the ECTS system based
on a yearly workload of 1600 h. We accept ECTSs obtained in
other European countries to the full. Our students get ECTS
points for the compulsory traineeship included in their degree.
Since the traineeship is 6 months, the points given are 30, i.e.,
5/month. All HEIs in Finland use ECTS-based credit points
since 2005.
The ECTSs gained before and after graduation are comparable.
4. Obstacles to mobility Yes The biggest obstacle to student mobility is the strictly
organized curriculum, which does not easily allow students to
move. If they are willing to prolong their studies by a half or
one year, mobility becomes much easier.
In reality, this means that most of our exchange students
choose to do their Master’s project abroad, because, by this
stage in their university career, they have fewer compulsory
courses.
Language and financial considerations are not major obstacles
to mobility.
5. Erasmus staff exchange to
HEI from elsewhere
Yes Number of staff months: 0.25
6. Erasmus staff exchange
from HEI to other HEIs
Yes Number of staff months: 0.25
7. Erasmus student exchange
to HEI from elsewhere
Yes Number of student months: circa 250
All over Europe
8. Erasmus student exchange
from HEI to other HEIs
Yes Number of student months: circa 50
Finland adopted the Bologna system with a two-tier degree system, the use of ECTS, etc.
The number of Erasmus and other exchange students increased steadily over the past 5-10 years.
3.6. Impact of European Union (EU) Directive 2013/55/EC [2]
Table 12 provides details on the various ways in which the EC directive impacts on pharmacy
education and training in Finland.
Finland conforms to the different aspects of the EU directive with a five-year degree and a
six-month traineeship. Suitable balance between theoretical studies and practical excercises is to be
found in order to reach the curriculum objects and learning outcomes of the B.Sc. and M.Sc. degrees.
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Table 12. Ways in which elements of the European Commission (EC) directive (left column) impacts
on Finnish pharmacy HEIs.
The Directive States How Does/Will This Directive Statement Affect Pharmacy
Education and Training?
“Evidence of formal qualifications as a
pharmacist shall attest to training of at least
five years’ duration . . . ”
This statement does not apply to the first-phase B.Sc. degree
in Pharmacy. This statement was obviously taken into
consideration when the curriculum for the M.Sc. (Pharm.)
degree was developed in 2006.
“ . . . four years of full-time theoretical and
practical training at a university or at a higher
institute of a level recognized as equivalent, or
under the supervision of a university”
Master students study 4.5 years at the university, so this
requirement is fulfilled.
“ . . . six-month traineeship in a pharmacy
which is open to the public or in a hospital,
under the supervision of that hospital’s
pharmaceutical department”
Both Bachelor and Master students perform the six-month
traineeship. At least three months have to be spent in a
community pharmacy and the remaining three months can
be spent in a community or hospital pharmacy.
The first three months of traineeship are performed in the
second study year and the second three months are
performed during the third year.
“The balance between theoretical and
practical training shall, in respect of each
subject, give sufficient importance to theory to
maintain the university character of the
training”
This point was object of intensive discussion during the
degree reform according to Bologna. From the university
point of view, we need to place emphasis on the theoretical
knowledge in order to prepare the students for further
studies (Ph.D.).
4. Discussion and Conclusions
We developed pharmacy education in Finland based on teacher and student feedback, and also
based on the field-specific feedback from societal stakeholders including community pharmacists,
hospital pharmacists, industrial pharmacists, and drug authority experts, and also according to the
recommendations and suggestions of the EAFP (European Association of Faculties in Pharmacy)-based
PHARMINE and PHAR-QA projects. One main point (but not the only point) is the close
correspondence of the Finnish system to the spirit of the essential points of the original Sorbonne 1998
declaration [3], as follows:
• University education will have
# a first-cycle degree (undergraduate, three years) with “international recognition of the
first cycle degree as an appropriate level . . . ”, providing the qualifications needed for
immediate employment.
# the above will be followed with a Master degree (M.Sc., two years), and eventually a Ph.D.
degree (four years)
• Qualifications in both cycles can be obtained in several EU countries; in an “extreme” case (going
beyond the typical case of a semester spent abroad), a foreign B.Sc. could be accepted as a
requirement for acceptance into the Finnish M.Sc. program.
The main conclusions/implications to be drawn from this survey of pharmacy education and
training in Finland are that it follows EU directives and additionally provides a description of the
two-tier Sorbonne/Bologna B.Sc./M.Sc. model.
Possible biases in our study could involve flaws in the representativity of the survey methodology.
However, given that Finland is a relatively small EU country with but three pharmacy departments
(Helsinki, Kuopio, Turku), we estimate that such biases are of little importance.
Pharmacy 2019, 7, 21 15 of 15
Author Contributions: J.H., O.S., K.V., H.H.—planning, writing, analysis and discussion of the curriculum
development and phamacists related tables in Finland, N.K.—pedagogic and curriculum development expertise,
J.A.—European level pharmacy expertise, leader of Pharmine and PHAR-QA EU-projects, international context
and comparisons.
Acknowledgments: The authors thank the Pharmacy Owners’ Association in Finland and the Finnish
Pharmacists’ Association.
Conflicts of Interest: The authors declare no conflicts of interest.
References
1. Atkinson, J.; Rombaut, B. The 2011 PHARMINE report on pharmacy and pharmacy education in the
European Union. Pharm. Pract. 2011, 9, 169–187. [CrossRef]
2. The European Commission Directive 2013/55/EU on Education and Training for Sectoral Practice Such
as That of Pharmacy. Available online: http://eur-lex.europa.eu/legal-content/FR/TXT/?uri=celex:
32013L0055 (accessed on 5 February 2019).
3. The European Higher Education Area (EHEA)—Bologna Agreement of Harmonisation of European
University Degree Courses. Available online: http://www.ehea.info/ (accessed on 5 February 2019).
4. Ministry of Health and Social Affairs. Medicines Policy. Available online: https://stm.fi/en/pharmaceutical-
service (accessed on 5 February 2019).
5. Ministry of Health and Social Affairs. Social Expenditure. Available online: https://stm.fi/en/expenditure
(accessed on 5 February 2019).
6. Erasmus Programme for Student and Staff Exchange in the EU. Available online: https://info.erasmusplus.
fr/ (accessed on 5 February 2019).
7. Atkinson, J. The Country Profiles of the PHARMINE Survey of European Higher Educational Institutions
Delivering Pharmacy Education and Training. Pharmacy 2017, 3, 34. [CrossRef] [PubMed]
8. Finnish Medicine’s Agency (FIMEA). Available online: https://www.fimea.fi/web/en (accessed on
5 February 2019).
9. EFPIA—The European Federation of Pharmaceutical Industries and Associations: The Pharmaceutical
Industry in Figures, Key Data 2017. Available online: https://www.efpia.eu/publications/downloads/
(accessed on 5 February 2019).
10. Akava—Confederation of Unions for Professional and Managerial Staff in Finland in 2008. Available
online: http://www.akava.fi/files/771/Akavalaiset_tyomarkkinat_2008.pdf (accessed on 5 February 2019).
(In Finnish)
11. Valvira (National supervisory authority for Welfare and Health). Available online: https://www.valvira.fi/
web/en (accessed on 5 February 2019).
12. AFP (Pharmacy Owners’ Association). Available online: https://www.apteekkariliitto.fi/en/association.
html (accessed on 5 February 2019).
13. SFL (Finnish Pharmacists’ Association). Available online: https://www.farmasialiitto.fi (accessed on
15 December 2018).
14. Language Requirements in Finnish or Swedish for B. Sc. and M. Sc. Degrees. Available online: https:
//www.helsinki.fi/en/admissions/proving-your-language-skills (accessed on 5 February 2019).
15. Courses Taught in English in Helsinki. Available online: https://guide.student.helsinki.fi/en (accessed on
5 February 2019).
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
